TY  - GEN
AU  - Montero-Conde, Cristina
AU  - Ruiz-Llorente, Sergio
AU  - Dominguez, Jose M
AU  - Knauf, Jeffrey A
AU  - Viale, Agnes
AU  - Sherman, Eric J
AU  - Ryder, Mabel
AU  - Ghossein, Ronald A
AU  - Rosen, Neal
AU  - Fagin, James A
PY  - 2013
UR  - https://hdl.handle.net/20.500.12105/27216
AB  - The RAF inhibitor vemurafenib (PLX4032) increases survival in patients with BRAF-mutant metastatic melanoma, but has limited efficacy in patients with colorectal cancers. Thyroid cancer cells are also comparatively refractory to RAF inhibitors. In...
LA  - eng
PB  - American Association for Cancer Research
TI  - Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF-mutant thyroid carcinomas.
TY  - research article
ER  -